Toward a new STATe: The role of STATs in mitochondrial function

Seminars in Immunology

Volumn 26, Issue 1, 2014, Pages 20-28

  Meier, Jeremy A ^a,b   Larner, Andrew C ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cancer; Ischemia reperfusion; Metabolism; Mitochondria; Review; STAT3; STATs

Indexed keywords

STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

CELL METABOLISM; CELL NUCLEUS; CELL STRESS; CELL VIABILITY; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY CHAIN; REVIEW;

CANCER; ISCHEMIA/REPERFUSION; METABOLISM; MITOCHONDRIA; REVIEW; STAT3; STATS;

ANIMALS; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANS-ACTIVATORS;

EID: 84896490633     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.12.005     Document Type: Review

References (79)

1. Wegrzyn J., Potla R., Chwae Y.J., Sepuri N.B., Zhang Q., Koeck T., et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
2. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
3. Szczepanek K., Lesnefsky E.J., Larner A.C. Multi-tasking: nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol 2012, 22:429-437.
4. Psarra A.M., Sekeris C.E. Glucocorticoid receptors and other nuclear transcription factors in mitochondria and possible functions. Biochim Biophys Acta 2009, 1787:431-436.
5. Tammineni P., Anugula C., Mohammed F., Anjaneyulu M., Larner A.C., Sepuri N.B. The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J Biol Chem 2013, 288:4723-4732.
6. Gough D.J., Koetz L., Levy D.E. The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and ras-mediated transformation. PLoS One 2013, 8:e83395.
7. Bernier M., Paul R.K., Martin-Montalvo A., Scheibye-Knudsen M., Song S., He H.J., et al. Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. J Biol Chem 2011, 286:19270-19279.
8. Elschami M., Scherr M., Philippens B., Gerardy-Schahn R. Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cells. Eur J Cell Biol 2013, 92:21-29.
9. Szczepanek K., Chen Q., Derecka M., Salloum F.N., Zhang Q., Szelag M., et al. Mitochondrial-targeted signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem 2011, 286:29610-29620.
10. Horvath C.M., Wen Z., Darnell J.E. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 1995, 9:984-994.
11. Phillips D., Reilley M.J., Aponte A.M., Wang G., Boja E., Gucek M., et al. Stoichiometry of STAT3 and mitochondrial proteins: Implications for the regulation of oxidative phosphorylation by protein-protein interactions. J Biol Chem 2010, 285:23532-23536.
12. Sarafian T.A., Montes C., Imura T., Qi J., Coppola G., Geschwind D.H., et al. Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS One 2010, 5:e9532.
13. Boengler K., Ungefug E., Heusch G., Schulz R. The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. Curr Pharm Des 2013, 19:6890-6895.
14. Lachance C., Goupil S., Leclerc P., Stattic V. a STAT3 inhibitor, affects human spermatozoa through regulation of mitochondrial activity. J Cell Physiol 2013, 228:704-713.
15. Schust J., Sperl B., Hollis A., Mayer T.U., Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006, 13:1235-1242.
16. Demaria M., Giorgi C., Lebiedzinska M., Esposito G., D'Angeli L., Bartoli A., et al. A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging (Albany NY) 2010, 2:823-842.
17. Nogueiras R., Habegger K.M., Chaudhary N., Finan B., Banks A.S., Dietrich M.O., et al. Sirtuin 1 and sirtuin 3: Physiological modulators of metabolism. Physiol Rev 2012, 92:1479-1514.
18. Nie Y., Erion D.M., Yuan Z., Dietrich M., Shulman G.I., Horvath T.L., et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 2009, 11:492-500.
19. Ahn B.H., Kim H.S., Song S., Lee I.H., Liu J., Vassilopoulos A., et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A 2008, 105:14447-14452.
20. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
21. Kim H.S., Patel K., Muldoon-Jacobs K., Bisht K.S., Aykin-Burns N., Pennington J.D., et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
22. Wunderlich C.M., Hovelmeyer N., Wunderlich F.T. Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT 2013, 2:e23878.
23. Nagata N., Matsuo K., Bettaieb A., Bakke J., Matsuo I., Graham J., et al. Hepatic src homology phosphatase 2 regulates energy balance in mice. Endocrinology 2012, 153:3158-3169.
24. Schaper F., Gendo C., Eck M., Schmitz J., Grimm C., Anhuf D., et al. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Biochem J 1998, 335(Pt 3):557-565.
25. Gianotti T.F., Castano G., Gemma C., Burgueno A.L., Rosselli M.S., Pirola C.J., et al. Mitochondrial DNA copy number is modulated by genetic variation in the signal transducer and activator of transcription 3 (STAT3). Metabolism 2011, 60:1142-1149.
26. Zhou L., Too H.P. Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS One 2011, 6:e21680.
27. Zhou L., Too H.P. GDNF family ligand dependent STAT3 activation is mediated by specific alternatively spliced isoforms of GFRalpha2 and RET. Biochim Biophys Acta 2013, 1833:2789-2802.
28. Zhang Q., Raje V., Yakovlev V.A., Yacoub A., Szczepanek K., Meier J., et al. Mitochondrial-localized Stat3 promotes breast cancer growth via phosphorylation of serine 727. J Biol Chem 2013, 288:31280-31288.
29. Ralph S.J., Rodríguez-Enríquez S., Neuzil J., Saavedra E., Moreno-Sánchez R. The causes of cancer revisited: "Mitochondrial malignancy" and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy. Mol Aspects Med 2010, 31:145-170.
30. Fruehauf J.P., Meyskens F.L. Reactive oxygen species: a breath of life or death?. Clin Cancer Res 2007, 13:789-794.
31. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat Rev Drug Discov 2009, 8:579-591.
32. Wang X., Crowe P.J., Goldstein D., Yang J.L. STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int J Oncol 2012, 41:1181-1191.
33. Mackenzie G.G., Huang L., Alston N., Ouyang N., Vrankova K., Mattheolabakis G., et al. Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice. PLoS One 2013, 8:e61532.
34. Kang R., Tang D., Lotze M.T., Zeh H.J. AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway. Autophagy 2012, 8:989-991.
35. Kang R., Tang D. Autophagy in pancreatic cancer pathogenesis and treatment. Am J Cancer Res 2012, 2:383-396.
36. Tateno T., Asa S.L., Zheng L., Mayr T., Ullrich A., Ezzat S. The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis. PLoS Genet 2011, 7:e1002400.
37. Boengler K., Hilfiker-Kleiner D., Heusch G., Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010, 105:771-785.
38. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007, 9:550-555.
39. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004, 427:461-465.
40. Giorgio V., von Stockum S., Antoniel M., Fabbro A., Fogolari F., Forte M., et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 2013, 110:5887-5892.
41. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
42. Halestrap A.P., Doran E., Gillespie J.P., O'Toole A. Mitochondria and cell death. Biochem Soc Trans 2000, 28:170-177.
43. Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S., Moll U.M. P53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012, 149:1536-1548.
44. Mantel C., Messina-Graham S., Moh A., Cooper S., Hangoc G., Fu X.Y., et al. Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. Blood 2012, 120:2589-2599.
45. Shulga N., Pastorino J.G. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J Cell Sci 2012, 125:2995-3003.
46. Szczepanek K., Chen Q., Larner A.C., Lesnefsky E.J. Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion 2012, 12:180-189.
47. Somers S.J., Frias M., Lacerda L., Opie L.H., Lecour S. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther 2012, 26:227-237.
48. Heusch G., Musiolik J., Gedik N., Skyschally A. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 2011, 109:1302-1308.
49. Boengler K., Buechert A., Heinen Y., Roeskes C., Hilfiker-Kleiner D., Heusch G., et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 2008, 102:131-135.
50. Penna C., Perrelli M.G., Tullio F., Angotti C., Camporeale A., Poli V., et al. Diazoxide postconditioning induces mitochondrial protein S-nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE. Basic Res Cardiol 2013, 108. 371-013-0371-z. Epub 2013 Jul 20.
51. Jeong K., Kwon H., Min C., Pak Y. Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts. Exp Mol Med 2009, 41:226-235.
52. Zhang M., Wei J., Shan H., Wang H., Zhu Y., Xue J., et al. Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy. PLoS One 2013, 8:e66779.
53. Zhang M., Wei J., Pan X., Shan H., Yan R., Xue J., et al. Change of cardiac mitochondrial STAT3 activity in rats with selenium deficiency and its relation with myocardial injury. Nan Fang Yi Ke Da Xue Xue Bao 2013, 33:967-971.
54. Halestrap A.P., Clarke S.J., Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res 2004, 61:372-385.
55. Shanmuganathan S., Hausenloy D.J., Duchen M.R., Yellon D.M. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005, 289:H237-H242.
56. Xie Y., Kole S., Precht P., Pazin M.J., Bernier M. S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology 2009, 150:1122-1131.
57. Zgheib C., Kurdi M., Zouein F.A., Gunter B.W., Stanley B.A., Zgheib J., et al. Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: Evidence that STAT3 signaling is redox-sensitive. PLoS One 2012, 7:e43313.
58. Butturini E., de Prati A.C., Chiavegato G., Rigo A., Cavalieri E., Darra E., et al. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoral cells to chemotherapeutic drugs. Free Radic Biol Med 2013, 65:1322-1330.
59. Kim J., Won J.S., Singh A.K., Sharma A.K., Singh I. STAT3 regulation by S-nitrosylation: implication for inflammatory disease. Antioxid Redox Signal 2013, epub ahead of print.
60. Li L., Cheung S.H., Evans E.L., Shaw P.E. Modulation of gene expression and tumor cell growth by redox modification of STAT3. Cancer Res 2010, 70:8222-8232.
61. Shaw P.E. Could STAT3 provide a link between respiration and cell cycle progression?. Cell Cycle 2010, 9:4294-4296.
62. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: From protection to failure. Pharmacol Ther 2008, 120:172-185.
63. Qiu H., Lizano P., Laure L., Sui X., Rashed E., Park J.Y., et al. H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of STAT3 and accelerates the transition into heart failure on cardiac overload. Circulation 2011, 124:406-415.
64. Jung J.E., Kim G.S., Narasimhan P., Song Y.S., Chan P.H. Regulation of mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J Neurosci 2009, 29:7003-7014.
65. Ao X., Fang F., Xu F. Vasoactive intestinal peptide protects alveolar epithelial cells against hyperoxia via promoting the activation of STAT3. Regul Pept 2011, 168:1-4.
66. Decker T., Kovarik P. Serine phosphorylation of STATs. Oncogene 2000, 19:2628-2637.
67. Lee H.J., Oh Y.K., Rhee M., Lim J.Y., Hwang J.Y., Park Y.S., et al. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. J Mol Biol 2007, 369:967-984.
68. DeVries T.A., Kalkofen R.L., Matassa A.A., Reyland M.E. Protein kinase cdelta regulates apoptosis via activation of STAT1. J Biol Chem 2004, 279:45603-45612.
69. Balasubramanian A., Ganju R.K., Groopman J.E. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis 2006, 194:670-681.
70. Goswami R., Majumdar T., Dhar J., Chattopadhyay S., Bandyopadhyay S.K., Verbovetskaya V., et al. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res 2013, 23:1025-1042.
71. Lartigue L., Faustin B. Mitochondria: metabolic regulators of innate immune responses to pathogens and cell stress. Int J Biochem Cell Biol 2013, 45:2052-2056.
72. Chueh F.Y., Leong K.F., Yu C.L. Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells. Biochem Biophys Res Commun 2010, 402:778-783.
73. Khan R., Lee J.E., Yang Y.M., Liang F.X., Sehgal P.B. Live-cell imaging of the association of STAT6-GFP with mitochondria. PLoS One 2013, 8:e55426.
74. Cimica V., Chen H.C., Iyer J.K., Reich N.C. Dynamics of the STAT3 transcription factor: Nuclear import dependent on ran and importin-beta1. PLoS One 2011, 6:e20188.
75. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 2007, 8:904-916.
76. Sorrentino G., Mioni M., Giorgi C., Ruggeri N., Pinton P., Moll U., et al. The prolyl-isomerase Pin1 activates the mitochondrial death program of p53. Cell Death Differ 2013, 20:198-208.
77. Lufei C., Koh T.H., Uchida T., Cao X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 2007, 26:7656-7664.
78. Lv L., Zhang J., Zhang L., Xue G., Wang P., Meng Q., et al. Essential role of Pin1 via STAT3 signalling and mitochondria-dependent pathways in restenosis in type 2 diabetes. J Cell Mol Med 2013, 17:989-1005.
79. Tavecchio M., Lisanti S., Lam A., Ghosh J.C., Martin N.M., O'Connell M., et al. Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility. J Biol Chem 2013, 288:5553-5561.